Biosimilar Newsletter Archive

  1. 04.07.22 -- Biosimilar Interchangeability: Regulatory & Practical Considerations 4/7/2022
    04/07/22 Biosimilar Development Newsletter
  2. 04.06.22 -- Emerging Bio Executives Tackle Regulatory, GMP And Talent Challenges 4/6/2022

    04/06/22 Biosimilar Development Newsletter

  3. 04.05.22 -- Listen Now: CAR T-cells for Ovarian Cancer, Cell and Gene Solid Tumor Therapies, and more. 4/5/2022
    04/05/22 Biosimilar Development Newsletter
  4. 04.04.22 -- Process Intensification Strategies To Maximize Productivity And Efficiency 4/4/2022

    04/04/22 Biosimilar Development Newsletter

  5. 03.31.22 -- OncyoBio Initiates Clinical Trial For First Biosimilar Product 3/31/2022
    03/31/22 Biosimilar Development Newsletter
  6. 03.30.22 -- Process Intensification Strategies To Maximize Productivity And Efficiency 3/30/2022

    03/30/22 Biosimilar Development Newsletter

  7. 03.24.22 -- Data Management: 5 Best Practices For Emerging Biotechs For Emerging 3/24/2022
    03/24/22 Biosimilar Development Newsletter
  8. 03.18.22 -- Enabling The Delivery Of Complex Biologics 3/18/2022

    03/18/22 Biosimilar Development Newsletter

  9. 03.17.22 -- FDA Offers Funding For Biosimilar Regulatory Science Pilot 3/17/2022
    03/17/22 Biosimilar Development Newsletter
  10. 03.10.22 -- Purify And Analyze His-Tagged Proteins 3/10/2022
    03/10/22 Biosimilar Development Newsletter